These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10837712)

  • 1. Cyclodextrin-based controlled drug release system.
    Hirayama F; Uekama K
    Adv Drug Deliv Rev; 1999 Mar; 36(1):125-141. PubMed ID: 10837712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmaceutical application of cyclodextrins as multi-functional drug carriers].
    Uekama K
    Yakugaku Zasshi; 2004 Dec; 124(12):909-35. PubMed ID: 15577263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of cyclodextrin-based drug formulation.
    Uekama K
    Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):900-15. PubMed ID: 15304981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.
    Salústio PJ; Pontes P; Conduto C; Sanches I; Carvalho C; Arrais J; Marques HM
    AAPS PharmSciTech; 2011 Dec; 12(4):1276-92. PubMed ID: 21948320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Cyclodextrins in Nanoparticle-Based Drug Delivery Systems.
    Shelley H; Babu RJ
    J Pharm Sci; 2018 Jul; 107(7):1741-1753. PubMed ID: 29625157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: in vitro evaluation and bioavailability studies in rabbits.
    Fernandes CM; Ramos P; Falcão AC; Veiga FJ
    J Control Release; 2003 Feb; 88(1):127-34. PubMed ID: 12586510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclodextrin-mesoporous silica particle composites for controlled antibiotic release. A proof of concept toward colon targeting.
    Stjern L; Voittonen S; Weldemichel R; Thuresson S; Agnes M; Benkovics G; Fenyvesi É; Malanga M; Yannakopoulou K; Feiler A; Valetti S
    Int J Pharm; 2017 Oct; 531(2):595-605. PubMed ID: 28554545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems.
    Brewster ME; Loftsson T
    Pharmazie; 2002 Feb; 57(2):94-101. PubMed ID: 11878196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclodextrins: structure, physicochemical properties and pharmaceutical applications.
    Jansook P; Ogawa N; Loftsson T
    Int J Pharm; 2018 Jan; 535(1-2):272-284. PubMed ID: 29138045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemically cross-linked and grafted cyclodextrin hydrogels: from nanostructures to drug-eluting medical devices.
    Concheiro A; Alvarez-Lorenzo C
    Adv Drug Deliv Rev; 2013 Aug; 65(9):1188-203. PubMed ID: 23631979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrin complexes: Perspective from drug delivery and formulation.
    Jacob S; Nair AB
    Drug Dev Res; 2018 Aug; 79(5):201-217. PubMed ID: 30188584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
    Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
    Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cyclodextrins on the proliferation of HaCaT keratinocytes in vitro.
    Hipler UC; Schönfelder U; Hipler C; Elsner P
    J Biomed Mater Res A; 2007 Oct; 83(1):70-9. PubMed ID: 17380497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomes incorporating cyclodextrin-drug inclusion complexes: Current state of knowledge.
    Gharib R; Greige-Gerges H; Fourmentin S; Charcosset C; Auezova L
    Carbohydr Polym; 2015 Sep; 129():175-86. PubMed ID: 26050903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery.
    Muankaew C; Loftsson T
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):46-55. PubMed ID: 29024354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supramolecular polymeric materials via cyclodextrin-guest interactions.
    Harada A; Takashima Y; Nakahata M
    Acc Chem Res; 2014 Jul; 47(7):2128-40. PubMed ID: 24911321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
    Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
    Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro drug release of natamycin from β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin-functionalized contact lens materials.
    Phan CM; Subbaraman LN; Jones L
    J Biomater Sci Polym Ed; 2014; 25(17):1907-19. PubMed ID: 25226305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Carrier Systems Based on Cyclodextrin Supramolecular Assemblies and Polymers: Present and Perspectives.
    Gonzalez-Gaitano G; Isasi JR; Velaz I; Zornoza A
    Curr Pharm Des; 2017; 23(3):411-432. PubMed ID: 27855609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.